NLRX1 and breast neoplasm: Likewise, the overexpression of NLRX1 in HEK293 (human embryonic kidney cells), MCF-7 (human ER/PR+ breast tumor cells), and HeLa (human cervical carcinoma cells) cell lines increased cell death and decreased ATP production (31, 32).